阿普斯特60片价格,阿普斯特片的最新价格
Apremilast is the first oral drug approved for the treatment of psoriasis in the past 20 years and the first oral drug approved for psoriatic arthritis in the past 15 years. Apremilast has been approved by the FDA and EMA regulatory agencies for the treatment of active psoriasis (PSA) and moderate to severe plaque psoriasis. Numerous clinical data show that after 16 weeks of treatment with Apremilast, psoriasis on nails, scalp, hands and feet was significantly improved and maintained throughout 52 weeks. What is the price of 60 tablets of Apremilast? What's the latest price?
It is understood that Apremilast is not currently on the market in China, so the domestic price of the drug cannot be provided. Patients can choose Apremilast, which is more cost-effective and available overseas. The prices and specifications of drugs sold in different countries or regions will vary. The price of Apremilast is also not fixed due to factors such as exchange rate fluctuations. If patients want to know more about Apremilast, For the specific price of Apremilast, or if you want to purchase the more cost-effective Apremilast overseas, and to learn more about the drug information of Apremilast, you can consult a reliable overseas medical service company in China (such as Medical Companion Travel). The method of purchasing medicines is overseas direct mail, and the medicines are delivered directly to patients. It is very convenient and fast, and is guaranteed to be authentic.
Apremilast related clinical trials
The safety and efficacy of Apremilast, a phosphodiesterase-4 (PDE-4) inhibitor, were evaluated in three clinical trials involving 1,493 patients with active psoriatic arthritis (PsA). Patients treated with Apremilast showed improvements in signs and symptoms of psoriatic arthritis (PsA), including tender and swollen joints and physical function, compared with placebo. Clinical trials show that the therapeutic effect of Apremilast is very significant.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended hot articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)